How big is this order relative to Veerhealth's revenue?

The ₹1.11 crore order represents about 3.4% of the company's latest annual revenue of ₹32.48 crore (FY26). It is small but material for a nano-cap.

Is this a repeat order or a new contract?

The filing states it is a new order, not a confirmation or repeat of any previously announced contract. The client is a large domestic pharmacy chain, whose identity is withheld.

What does this mean for Veerhealth's business mix?

It diversifies the company's revenue beyond its existing FMCG-focused contract manufacturing into the healthcare distribution channel, potentially reducing customer concentration.

Has Veerhealth won other orders recently?

Yes, on June 9, 2026, the company announced a ₹3.6 crore face-care order from an undisclosed FMCG client. This is the second sizable order in about a month.

What is the company's financial health?

Veerhealth has a market cap of ₹61 crore, trailing revenue growth of 198% but negative PAT. Its latest quarter (Mar 2026) showed sales of ₹17 crore and near-zero net profit. The company recently raised ₹20.25 crore via warrants, diluting 31% of equity.

How soon will the order revenue be recognized?

The order has a 45-day execution timeline from the announcement date (July 11), so revenue should be recognized within Q2 FY27.

Order Wins · Pharmaceuticals · Micro cap

Veerhealth Care lands ₹1.11 cr order from pharmacy chain, opens new channel

Veerhealth Care won a ₹1.11 crore order for haircare and oral care products from a large domestic pharmacy chain, marking its entry into the healthcare distribution channel alongside its existing FMCG contract manufacturing business.

— 4 earlier stories on Veerhealth Care Ltd. →

NIYATILEAS By Tipsheet Editorial 11 Jul 2026 · 4:33 PM IST Verify on BSE · NSE

Mkt cap₹61.4 cr

P/E112.66×

ROE1.76%

Debt / eq.0.22

₹1.11 cr Order value for haircare and oral care supply

What's new

Veerhealth Care received a ₹1.11 crore order for haircare and oral care products from a large domestic pharmacy chain.
The order is to be executed within 45 days; client identity is confidential.
This marks the company's entry into a new distribution channel in healthcare, diversifying from its FMCG-focused contract manufacturing.

Why this matters

Though modest at just 3.4% of annual revenue, the order opens a new distribution channel and reduces reliance on FMCG clients. It also follows a ₹3.6 crore face-care order in June, suggesting growing commercial traction. For a company with a ₹61 crore market cap and thin profitability, every incremental revenue source helps.

What we're watching

Whether more healthcare-distribution orders follow, confirming a new revenue stream.
Execution: the 45-day timeline is tight; any delays could strain credibility.
Profitability of this channel vs. existing FMCG business — margins aren't disclosed.

The full read

Veerhealth Care has bagged a ₹1.11 crore order to supply haircare and oral care products to a large domestic pharmacy chain — a new customer segment and distribution channel for a company that has mostly served FMCG clients. The order, while modest at 3.4% of FY26 revenue of ₹32.48 crore, is to be executed within 45 days, providing near-term cash flow. This is Veerhealth's second supply order in just over a month, following a ₹3.6 crore face-care order in June. For a company with a ₹61 crore market cap, thin profitability (near-zero net profit in the March quarter), and a recent 31% equity dilution from a ₹20.25 crore warrant issue, every incremental revenue stream matters. The undisclosed client and new channel add a layer of diversification that could reduce dependence on any single segment. The open question: whether this is a one-off or the start of a repeatable healthcare-distribution revenue line.

Questions answered

How big is this order relative to Veerhealth's revenue?: The ₹1.11 crore order represents about 3.4% of the company's latest annual revenue of ₹32.48 crore (FY26). It is small but material for a nano-cap.
Is this a repeat order or a new contract?: The filing states it is a new order, not a confirmation or repeat of any previously announced contract. The client is a large domestic pharmacy chain, whose identity is withheld.
What does this mean for Veerhealth's business mix?: It diversifies the company's revenue beyond its existing FMCG-focused contract manufacturing into the healthcare distribution channel, potentially reducing customer concentration.
Has Veerhealth won other orders recently?: Yes, on June 9, 2026, the company announced a ₹3.6 crore face-care order from an undisclosed FMCG client. This is the second sizable order in about a month.
What is the company's financial health?: Veerhealth has a market cap of ₹61 crore, trailing revenue growth of 198% but negative PAT. Its latest quarter (Mar 2026) showed sales of ₹17 crore and near-zero net profit. The company recently raised ₹20.25 crore via warrants, diluting 31% of equity.
How soon will the order revenue be recognized?: The order has a 45-day execution timeline from the announcement date (July 11), so revenue should be recognized within Q2 FY27.

Mentioned: ₹1.11 crores order · pharmacy chain · 45-day execution

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Veerhealth Care Ltd.

Pharmaceuticals

₹65 cr

P/E 119.51×

Latest quarter · Mar 2026

Sales₹17 cr

Net profit−₹0 cr

Op. margin+4.4%

EPS−₹0.18

Strength & growth

Debt / equity0.22×

Current ratio3.06×

Sales CAGR+31.1%

EPS CAGR+14.3%

Story so far

All notes on NIYATILEAS →

11 Jul 2026 · 4:33 PM IST Veerhealth Care lands ₹1.11 cr order from pharmacy chain, opens new channel
9d ago Veerhealth Care dilutes 31% of equity with ₹20.25 cr warrant issue
32d ago Veerhealth lands ₹3.6 cr face-care order from undisclosed FMCG client
42d ago Veerhealth Care revenue nearly doubles to ₹32.5 cr, but Q4 slips to a loss
47d ago Veerhealth Care's board meets to approve FY26 results and weigh a dividend